Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Market Access Transformation

Request full access

Market Access Transformation - Rapid Payer Response™

United StatesFounded 2015Health

About Market Access Transformation

Market Access Transformation (MAT), established in 2016 by industry veterans Baiju Aurora and Paul Howard, operates as a specialized technology and research firm within the pharmaceutical sector. The company was acquired by Genesis Research in May 2022 and now functions as a subsidiary. Baiju Aurora, the CEO, has a background that spans various roles in the pharmaceutical industry, including positions at Roche, Allergan, and Market Access Solutions, equipping him with extensive experience in business development, pricing, and market access. His journey reflects a deep-seated expertise in the commercial aspects of pharmaceuticals, which is central to MAT's mission.

MAT's business model is centered on providing technology-enabled research platforms for life sciences companies to assess the commercial viability of their products. Revenue is generated through client partnerships, with over 50 of the leading pharmaceutical manufacturers utilizing their services, and a reported 93% license renewal rate for their primary platform. The company serves a global market, with a network spanning over 50 countries, targeting pharmaceutical and biotech manufacturers as its primary clients.

The firm's core offering is its proprietary SaaS platform, Rapid Payer Response™ (RPR), launched in July 2016. RPR allows pharmaceutical companies to gather insights from a global, vetted network of payers—the entities that finance or reimburse the cost of health products. This platform significantly shortens the research timeline, providing feedback in days rather than the months required by traditional methods, and at a reduced cost. In February 2022, MAT launched Envision™, a syndicated research platform focused on providing early forecasts on the market access viability of products, particularly in oncology, that have received positive regulatory guidance from bodies like the FDA or EMA.

Source: Dealroom company data

Market Access Transformation in its local ecosystem

Live from Dealroom

The Market Access Transformation office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

  • Silversmith Capital Partners
Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Market Access Transformation on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Market Access Transformation on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.